The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group
of disorders involving severe, systemic, small-vessel vasculitis and are characterized by …

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is the most common
cause of rapidly progressive glomerulonephritis worldwide, and the renal biopsy is the gold …

In the past years, many (randomized) trials have been performed comparing the treatment
strategies for lupus nephritis. In 2012, these data were incorporated in six different guidelines …

Objectives Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)
treated with cyclophosphamide have an increased malignancy risk compared with the …

Histopathological features in renal biopsies of patients with antineutrophil cytoplasmic
antibody–associated vasculitis have predictive value for renal outcome in patients who receive …

The changes in bone marrow (BM) stem cell reserve and function and stromal cell function
in patients with active systemic lupus erythematosus (SLE) were investigated. The study was …

To the Editor: Alemtuzumab (Campath-1H) is a humanized anti-CD52 monoclonal antibody,
the administration of which causes profound B- and T-lymphocyte depletion. It is licensed for …

Background: Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis is a serious,
often life-threatening disease. In new-onset disease or a relapse, the standard treatment is …

Background Assessing inflammatory disease activity in large vessel vasculitis (LVV) can be
challenging by conventional measures. Objectives We aimed to investigate somatostatin …

Objective. There are differences in the frequencies of antineutrophil cytoplasmic antibodies (ANCA)–associated
vasculitis subgroups between different geographic regions, and we …